Syneos Health, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2013 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Syneos Health, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2013 to Q4 2022.
  • Syneos Health, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2022 was $99.5M, a 1.59% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $99.5M +$1.56M +1.59% Dec 31, 2022 10-K 2023-02-16
Q4 2021 $98M -$2.35M -2.34% Dec 31, 2021 10-K 2023-02-16
Q4 2020 $100M +$16.2M +19.2% Dec 31, 2020 10-K 2022-02-17
Q4 2019 $84.2M -$66.2M -44% Dec 31, 2019 10-K 2021-02-18
Q4 2018 $150M -$9.33M -5.84% Dec 31, 2018 10-K 2020-02-20
Q4 2017 $160M +$154M +2948% Dec 31, 2017 10-K 2019-03-18
Q4 2016 $5.24M -$11.5M -68.7% Dec 31, 2016 10-K 2018-02-28
Q4 2015 $16.7M -$31.9M -65.6% Dec 31, 2015 10-K 2017-02-28
Q4 2014 $48.7M +$2.2M +4.73% Dec 31, 2014 10-K 2016-02-25
Q4 2013 $46.5M Dec 31, 2013 10-K 2015-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.